ProCE Banner Activity

Current Therapeutic Strategies for Advanced Melanoma

Clinical Thought

An updated treatment landscape overview for APPs who treat advanced and metastatic melanoma, including recent data with immune checkpoint inhibitors, tyrosine kinase inhibitors, and other therapeutic modalities

Released: May 31, 2023

Share

Faculty

Megan Schollenberger

Megan Schollenberger, MSN, CRNP

Senior Nurse Practitioner
Melanoma and Cancer Immunology Programs
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Baltimore, Maryland

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

Disclosure

Primary Author

Megan Schollenberger, MSN, CRNP

Senior Nurse Practitioner
Melanoma and Cancer Immunology Programs
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Baltimore, Maryland

Megan Schollenberger, MSN, CRNP, has no relevant conflicts of interest to report.